XML 159 R56.htm IDEA: XBRL DOCUMENT v3.24.1
Insider Trading Arrangements
 3 Months Ended
Dec. 31, 2023
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted true
Dr. Aaron Fletcher  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

During the three months ended December 31, 2023, the following directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(c) of Regulation S-K:

​

Name and Title

Action

Date

Plan

Aggregate Number of securities to be sold

Plan Expiration Date

Aaron Fletcher, Director(1)

Adoption

December 29, 2023

Rule 10b5-1

2,000,000

March 28, 2025

​

(1) The plan was adopted by BIOS Equity Partners, LP. BIOS Capital Management, LP is the general partner of BIOS Equity Partners, LP. Bios Advisors GP, LLC, an entity controlled by Dr. Aaron Fletcher, is the general partner of Bios Management. As the manager of Bios Advisors, Dr. Fletcher may be deemed to have shared voting and/or dispositive power with respect to shares directly or indirectly held by the

BIOS Equity Partners LP.
Name Aaron Fletcher
Title Director